Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 0.1470
+0.0005 (0.34%)
Sep 4, 2026, 5:29 PM CET
Prostatype Genomics AB Employees
Prostatype Genomics AB had 7 employees as of December 31, 2025. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change
1
Growth
16.67%
Revenue / Employee
144.86K SEK
Profits / Employee
-5.41M SEK
Market Cap
82.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7 | 1 | 16.67% |
| Jun 30, 2025 | 6 | - | - |
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | 0 | - |
| Mar 31, 2023 | 6 | 1 | 20.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Sep 30, 2022 | 6 | 0 | - |
| Jun 30, 2022 | 4 | 0 | - |
| Mar 31, 2022 | 5 | 1 | 25.00% |
| Dec 31, 2021 | 5 | 0 | - |
| Sep 30, 2021 | 6 | 0 | - |
| Jun 30, 2021 | 4 | -2 | -33.33% |
| Mar 31, 2021 | 4 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 49,000 |
| Getinge AB | 11,758 |
| Swedish Orphan Biovitrum AB | 2,119 |
| Sectra AB | 1,436 |
| IDL Diagnostics AB | 25 |
| Immunovia AB | 18 |
| Ascelia Pharma AB | 10 |
| Newbury Pharmaceuticals AB | 7 |
Prostatype Genomics AB News
- 5 days ago - Prostatype Genomics AB Quarterly report: Q2 2026 - Filings
- 6 months ago - Prostatype Genomics AB Quarterly report: Q4 2025 - Filings
- 6 months ago - Prostatype Genomics AB Annual report: Q4 2025 - Filings
- 9 months ago - Prostatype Genomics AB Transcript: Life Science Summit 2025 - Transcripts